Kura Oncology (KURA) Stock
Kura Oncology (KURA) closed at $7.49 on Nov 17, 2026; its Tenet Score is 30 of 100 against 340 Healthcare peers.
26 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $7.49
- Nov 17, 2026
- Market cap
- $651.4M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 6.75 – 13.90
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 30/100
- Weak · 340 Healthcare peers
Industry: Drugs
Kura Oncology Inc scores 30/100. Weak. Value is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 30 is built from 3 of 4 pillars, from 45% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are zi…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Annexon IncANNX | 37 | $733.7M |
| Universe Pharmaceuticals INCUPC | 62 | $674.7M |
| Janux Therapeutics IncJANX | 74 | $668.1M |
| Olema Oncology Inc.OLMA | 56 | $644.8M |
| Arbutus Biopharma CorpABUS | 58 | $619.3M |
| Cullinan Therapeutics IncCGEM | 55 | $616.7M |
| Geron Corp.GERN | 55 | $606.8M |
| Climb Bio Inc.CLYM | 62 | $583.9M |
| Wave Life Sciences Inc.WVE | 54 | $566.0M |
| Sana Biotechnology IncSANA | 36 | $563.3M |
Common questions
What sector and industry is Kura Oncology in?
Kura Oncology is in the Healthcare sector and the Drugs industry.
What is Kura Oncology's Tenet Score?
Kura Oncology's Tenet Score is 30 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




